{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vascularite lupique du système nerveux central : Questions médicales les plus fréquentes",
"headline": "Vascularite lupique du système nerveux central : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vascularite lupique du système nerveux central : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-19",
"dateModified": "2026-08-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vascularite lupique du système nerveux central"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Lupus érythémateux disséminé",
"url": "https://questionsmedicales.fr/mesh/D008180",
"about": {
"@type": "MedicalCondition",
"name": "Lupus érythémateux disséminé",
"code": {
"@type": "MedicalCode",
"code": "D008180",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.111.590"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Vascularite lupique du système nerveux central",
"alternateName": "Lupus Vasculitis, Central Nervous System",
"code": {
"@type": "MedicalCode",
"code": "D020945",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Rula A Hajj-Ali",
"url": "https://questionsmedicales.fr/author/Rula%20A%20Hajj-Ali",
"affiliation": {
"@type": "Organization",
"name": "Cleveland Clinic Center for Vasculitis Care and Research, Cleveland Clinic, 9500 Euclid Avenue, A50, Cleveland, OH 44195, USA. Electronic address: HAJJALR@ccf.org."
}
},
{
"@type": "Person",
"name": "David S Younger",
"url": "https://questionsmedicales.fr/author/David%20S%20Younger",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Division of Neuro-Epidemiology, New York University School of Medicine, New York, NY, USA; School of Public Health, City University of New York, New York, NY, USA. Electronic address: youngd01@nyu.edu."
}
},
{
"@type": "Person",
"name": "Carlo Salvarani",
"url": "https://questionsmedicales.fr/author/Carlo%20Salvarani",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA; Rheumatology Division, Azienda USL-IRCCS di Reggio Emilia e Università di Modena e Reggio Emilia, Reggio Emilia, Italy. Electronic address: carlo.salvarani@ausl.re.it."
}
},
{
"@type": "Person",
"name": "Robert D Brown",
"url": "https://questionsmedicales.fr/author/Robert%20D%20Brown",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA."
}
},
{
"@type": "Person",
"name": "John Huston",
"url": "https://questionsmedicales.fr/author/John%20Huston",
"affiliation": {
"@type": "Organization",
"name": "Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Primary central nervous system vasculitis with intracranial aneurysm.",
"datePublished": "2024-06-29",
"url": "https://questionsmedicales.fr/article/38970897",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.semarthrit.2024.152506"
}
},
{
"@type": "ScholarlyArticle",
"name": "Central nervous system vasculitis in VEXAS syndrome: A rare involvemen.",
"datePublished": "2024-05-23",
"url": "https://questionsmedicales.fr/article/38801808",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.clineuro.2024.108351"
}
},
{
"@type": "ScholarlyArticle",
"name": "Primary central nervous system vasculitis and headache: Ten themes.",
"datePublished": "2023-10-16",
"url": "https://questionsmedicales.fr/article/37865827",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/WCO.0000000000001225"
}
},
{
"@type": "ScholarlyArticle",
"name": "Syndrome of inappropriate antidiuretic hormone release secondary to central nervous system coccidioidomycosis with vasculitis.",
"datePublished": "2024-03-29",
"url": "https://questionsmedicales.fr/article/38553023",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bcr-2023-258915"
}
},
{
"@type": "ScholarlyArticle",
"name": "Vasculitis in the Central Nervous System: Etiology, Characteristics, and Outcomes in a Large Single-Center Cohort.",
"datePublished": "2023-12-18",
"url": "https://questionsmedicales.fr/article/38666288",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/19418744231223283"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies auto-immunes",
"item": "https://questionsmedicales.fr/mesh/D001327"
},
{
"@type": "ListItem",
"position": 4,
"name": "Lupus érythémateux disséminé",
"item": "https://questionsmedicales.fr/mesh/D008180"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vascularite lupique du système nerveux central",
"item": "https://questionsmedicales.fr/mesh/D020945"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vascularite lupique du système nerveux central - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vascularite lupique du système nerveux central",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-09-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vascularite lupique du système nerveux central",
"description": "Comment diagnostiquer la vascularite lupique ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels signes cliniques indiquent une vascularite lupique ?\nLa biopsie est-elle nécessaire pour le diagnostic ?\nQuels marqueurs sanguins sont associés au lupus ?",
"url": "https://questionsmedicales.fr/mesh/D020945#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vascularite lupique du système nerveux central",
"description": "Quels sont les symptômes courants de cette vascularite ?\nLa fatigue est-elle un symptôme fréquent ?\nPeut-on avoir des troubles de l'humeur ?\nLes symptômes neurologiques sont-ils réversibles ?\nY a-t-il des symptômes spécifiques aux enfants ?",
"url": "https://questionsmedicales.fr/mesh/D020945#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vascularite lupique du système nerveux central",
"description": "Peut-on prévenir la vascularite lupique ?\nQuels conseils de mode de vie peuvent aider ?\nLes vaccinations sont-elles importantes ?\nFaut-il éviter certains médicaments ?\nLe stress peut-il aggraver la condition ?",
"url": "https://questionsmedicales.fr/mesh/D020945#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vascularite lupique du système nerveux central",
"description": "Quels traitements sont utilisés pour la vascularite lupique ?\nLes traitements sont-ils efficaces ?\nY a-t-il des effets secondaires aux traitements ?\nLa physiothérapie est-elle recommandée ?\nLes traitements sont-ils à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D020945#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vascularite lupique du système nerveux central",
"description": "Quelles sont les complications possibles ?\nLa vascularite peut-elle entraîner des séquelles ?\nY a-t-il un risque accru de démence ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications ?",
"url": "https://questionsmedicales.fr/mesh/D020945#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vascularite lupique du système nerveux central",
"description": "Quels sont les facteurs de risque pour cette maladie ?\nL'âge joue-t-il un rôle dans le risque ?\nLes infections peuvent-elles déclencher la maladie ?\nLe tabagisme est-il un facteur de risque ?\nLes facteurs environnementaux influencent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D020945#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la vascularite lupique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'évaluation clinique, l'imagerie cérébrale et des analyses sanguines."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les IRM, les analyses de sang et les ponctions lombaires sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une vascularite lupique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des maux de tête, des troubles cognitifs et des crises convulsives peuvent indiquer cette condition."
}
},
{
"@type": "Question",
"name": "La biopsie est-elle nécessaire pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une biopsie cérébrale peut être envisagée si les autres tests ne sont pas concluants."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sanguins sont associés au lupus ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anticorps anti-nucléaires (ANA) et anti-DNA sont souvent présents chez les patients."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de cette vascularite ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maux de tête, des troubles de la vision et des convulsions."
}
},
{
"@type": "Question",
"name": "La fatigue est-elle un symptôme fréquent ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fatigue est courante chez les patients atteints de vascularite lupique."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des troubles de l'humeur ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de l'humeur comme la dépression peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les symptômes neurologiques sont-ils réversibles ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains symptômes peuvent être réversibles avec un traitement approprié."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux enfants ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants peuvent présenter des symptômes similaires, mais souvent plus aigus."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la vascularite lupique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention, mais un suivi régulier peut aider."
}
},
{
"@type": "Question",
"name": "Quels conseils de mode de vie peuvent aider ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, est conseillé."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations peuvent prévenir certaines infections chez les patients immunodéprimés."
}
},
{
"@type": "Question",
"name": "Faut-il éviter certains médicaments ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent aggraver les symptômes et doivent être évités."
}
},
{
"@type": "Question",
"name": "Le stress peut-il aggraver la condition ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut exacerber les symptômes et doit être géré."
}
},
{
"@type": "Question",
"name": "Quels traitements sont utilisés pour la vascularite lupique ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les corticostéroïdes et les immunosuppresseurs sont couramment prescrits."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la plupart des patients répondent bien aux traitements, réduisant les symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires aux traitements ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les effets secondaires peuvent inclure des infections et des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "La physiothérapie est-elle recommandée ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La physiothérapie peut aider à la réhabilitation neurologique après des symptômes."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils à long terme ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi à long terme est souvent nécessaire pour gérer la maladie."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des AVC, des troubles cognitifs et des crises épileptiques."
}
},
{
"@type": "Question",
"name": "La vascularite peut-elle entraîner des séquelles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des séquelles neurologiques peuvent persister après un épisode aigu."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de démence ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients peuvent avoir un risque accru de démence en raison de lésions cérébrales."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier avec des examens neurologiques et des imageries est essentiel."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour cette maladie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux de lupus et le sexe féminin augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la vascularite lupique est plus fréquente chez les jeunes adultes et les femmes."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles déclencher la maladie ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections peuvent déclencher ou aggraver la vascularite lupique."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut augmenter le risque de complications chez les patients lupiques."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux influencent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certains produits chimiques peut augmenter le risque de lupus."
}
}
]
}
]
}
Cleveland Clinic Center for Vasculitis Care and Research, Cleveland Clinic, 9500 Euclid Avenue, A50, Cleveland, OH 44195, USA. Electronic address: HAJJALR@ccf.org.
Publications dans "Vascularite lupique du système nerveux central" :
Department of Neurology, Division of Neuro-Epidemiology, New York University School of Medicine, New York, NY, USA; School of Public Health, City University of New York, New York, NY, USA. Electronic address: youngd01@nyu.edu.
Publications dans "Vascularite lupique du système nerveux central" :
Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA; Rheumatology Division, Azienda USL-IRCCS di Reggio Emilia e Università di Modena e Reggio Emilia, Reggio Emilia, Italy. Electronic address: carlo.salvarani@ausl.re.it.
Publications dans "Vascularite lupique du système nerveux central" :
Department of Advanced Medical and Surgical Sciences (DAMSS), University of Campania "Luigi Vanvitelli", Piazza L. Miraglia 2, 80138, Naples, Italy.
Clinical Department of Laboratory Services and Public Health-Legal Medicine Unit, University of Campania "Luigi Vanvitelli", via Luciano Armanni 5, 80138, Naples, Italy.
Pathology-Unit of Federico II University, via S. Pansini 3, 80131, Naples, Italy.
Publications dans "Vascularite lupique du système nerveux central" :
Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA, 19104, USA. jae.song@pennmedicine.upenn.edu.
Publications dans "Vascularite lupique du système nerveux central" :
Unruptured intracranial aneurysms (UIAs) are rarely reported in primary central nervous system vasculitis (PCNSV). In this study we described the clinical findings, response to therapy, and outcomes o...
We retrospectively studied 216 consecutive patients with PCNSV, selected by predetermined diagnostic criteria, who were seen during a 40-year period. UIAs were identified on cerebral angiography. The ...
12/216 (5.5 %) PCNSV patients had at least one UIA. Two patients underwent biopsies; one yielded negative results, while the other showed necrotizing vasculitis. Eleven patients had evidence of UIA on...
UIAs uncommonly occur in PCNSV....
VEXAS (Vacuoles, E1 Enzyme, X-linked, autoinflammatory, Somatic) syndrome is a recently described severe adult-onset autoinflammatory disorder mediated by X-linked gene UBA1 somatic mutations, respons...
We report the first central nervous system (CNS) vasculitis in VEXAS syndrome, characterized by headache, cognitive dysfunction and focal signs (cerebellar ataxia). Magnetic resonance imaging (MRI) re...
CNS vasculitis, occurring as a manifestation of the systemic auto-inflammatory state of VEXAS syndrome, might be a rare but severe complication. We suggest that it be added to the list of inflammatory...
The primary central nervous system (CNS) vasculitides refers to clinicopathologic disorders that share the histopathology of inflammation of cerebral or spinal blood vessels. Unrecognized and therefor...
Headache is an important clue to vasculitic involvement of CNS vessels. CNS vasculitis can be primary, in which only intracranial or spinal vessels are involved in the inflammatory process, or seconda...
Primary CNS vasculitides can be diagnosed with certainty after intensive evaluation that includes tissue confirmation whenever possible. As in its systemic counterparts, clinicians must choose from am...
A man in his 60s presented to the clinic due to night sweats and weight loss following pneumonia. He was found to have hyponatraemia due to a syndrome of inappropriate antidiuretic hormone (SIADH). CT...
For the management of central nervous system (CNS) vasculitis, it is crucial to differentiate between primary and secondary CNS vasculitis and to understand the respective etiologies. We assessed the ...
A single-center retrospective chart review was conducted at the University of Utah, Department of Neurology, between February 2011 and October 2022....
The median age of the 44 included patients at diagnosis was 54 years; 25.0% were men. Compared to primary CNS vasculitis, secondary CNS vasculitis exhibits higher fever incidence (observed in infectio...
This study highlights the variations in patients' characteristics, symptoms, and treatment for CNS vasculitis. Understanding these differences can lead to more efficient diagnostic and management stra...
To measure the expression level of the vacuolar protein sorting 13 (VPS13) gene and stimulator of interferon genes (STING) in patients with SLE with and without reported neuropsychiatric symptoms to e...
This study included 100 subjects: 50 patients diagnosed with SLE and 50 age-matched and sex-matched healthy participants as the control group. The patients with SLE were further subdivided into NPSLE ...
Seventy-eight per cent of the SLE group were classified as non-NPSLE, and 22% were classified as NPSLE. Positive MRI results were found in 55% of the patients with NPSLE and 7.7% of the patients witho...
The VPS13C expression levels were decreased in patients with NPSLE compared with patients without NPSLE, while STING expression levels showed higher levels in NPSLE. Both were associated with the MRI ...
Central nervous system vasculitis (CNSV) is a rare disease. High-resolution vessel wall imaging (HR-VWI) enables the identification of inflammatory changes within the vessel wall. Few studies have app...
Imaging data were acquired from children who underwent HR-VWI examinations. The study meticulously analysed clinical data and laboratory tests to discern the characteristics and distribution patterns ...
In children, CNSV mainly involves medium vessels with grade 1 and 2 stenosis (grade 4 stenosis is rare), and the imaging features generally show centripetal and moderate enhancement, suggesting that t...
This study underscores the diagnostic value of HR-VWI in CNSV assessment and treatment monitoring, offering a quantitative evaluation of CNSV in children....
This study investigated the topological structural characteristics of systemic lupus erythematosus (SLE) with and without neuropsychiatric symptoms (NPSLE and non-NPSLE), and explore their clinical im...
We prospectively recruited 50 patients with SLE (21 non-NPSLE and 29 NPSLE) and 32 age-matched healthy controls (HCs), using MRI diffusion tensor imaging. Individual structural networks were construct...
Patients with oth non-NPSLE and NPSLE exhibited significant global and local topological alterations compared with HCs. These changes were more pronounced in NPSLE, particularly affecting the default ...
Structural networks in patients SLE may be altered at both global and local levels, with more pronounced changes observed in NPSLE, notably affecting the default mode and sensorimotor networks. These ...
Given the growing popularity of Rituximab (Rmab) treatment as a potential substitute for cyclophosphamide, we conducted this review to determine aspects related to Rmab therapy in central nervous syst...